ATE540039T1 - Neue derivate von (verbrücktes piperazinyl)-1- alcanon und deren verwendung als p75-inhibitoren - Google Patents

Neue derivate von (verbrücktes piperazinyl)-1- alcanon und deren verwendung als p75-inhibitoren

Info

Publication number: ATE540039T1
Authority: AT; Austria
Prior art keywords: alcanone; inhibitors; new derivatives; bridged piperazinyl; piperazinyl
Prior art date: 2008-06-13

Application number

AT09761939T

Other languages

English (en)

Inventor

Marco Baroni

Francoise Bono

Sandrine Delbary-Gossart

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-13

Filing date

2009-06-12

Publication date

2012-01-15

2009-06-12 Application filed by Sanofi Sa filed Critical Sanofi Sa

2012-01-15 Application granted granted Critical

2012-01-15 Publication of ATE540039T1 publication Critical patent/ATE540039T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Hematology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

AT09761939T 2008-06-13 2009-06-12 Neue derivate von (verbrücktes piperazinyl)-1- alcanon und deren verwendung als p75-inhibitoren ATE540039T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0803299A FR2932482B1 (fr)	2008-06-13	2008-06-13	Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75
PCT/FR2009/051118 WO2009150388A1 (fr)	2008-06-13	2009-06-12	NOUVEAUX DERIVES DE (PIPERAZINYL PONTE)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75

Publications (1)

Publication Number	Publication Date
ATE540039T1 true ATE540039T1 (de)	2012-01-15

Family

ID=40305395

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09761939T ATE540039T1 (de)	2008-06-13	2009-06-12	Neue derivate von (verbrücktes piperazinyl)-1- alcanon und deren verwendung als p75-inhibitoren

Country Status (38)

Country	Link
US (2)	US8193190B2 (de)
EP (1)	EP2297148B8 (de)
JP (1)	JP5476373B2 (de)
KR (1)	KR101642526B1 (de)
CN (1)	CN102124006B (de)
AR (1)	AR072103A1 (de)
AT (1)	ATE540039T1 (de)
AU (1)	AU2009259121B2 (de)
BR (1)	BRPI0915126B8 (de)
CA (1)	CA2727669C (de)
CL (1)	CL2010001429A1 (de)
CO (1)	CO6280535A2 (de)
CR (1)	CR11832A (de)
CY (1)	CY1112610T1 (de)
DK (1)	DK2297148T3 (de)
DO (2)	DOP2010000380A (de)
EA (1)	EA019074B1 (de)
EC (1)	ECSP10010672A (de)
ES (1)	ES2379685T3 (de)
FR (1)	FR2932482B1 (de)
HR (1)	HRP20120290T1 (de)
IL (1)	IL209902A (de)
JO (1)	JO2774B1 (de)
MA (1)	MA32474B1 (de)
MX (1)	MX2010013695A (de)
MY (1)	MY150988A (de)
NI (1)	NI201000215A (de)
NZ (1)	NZ589840A (de)
PE (1)	PE20110154A1 (de)
PL (1)	PL2297148T3 (de)
PT (1)	PT2297148E (de)
RS (1)	RS52262B (de)
SI (1)	SI2297148T1 (de)
SV (1)	SV2010003755A (de)
TW (1)	TWI432433B (de)
UA (1)	UA101979C2 (de)
UY (1)	UY31893A (de)
WO (1)	WO2009150388A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2931223B1 (fr)	2008-05-16	2010-08-20	Air Liquide	Dispositif distributeur de gaz sous pression, ensemble comprenant un tel dispositif et dispositif de commande, recipient pourvu d'un tel dispositif distributeur
FR2932481B1 (fr) *	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2953836B1 (fr)	2009-12-14	2012-03-16	Sanofi Aventis	Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
FR2953839A1 (fr) *	2009-12-14	2011-06-17	Sanofi Aventis	Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75
EP2606894A1 (de)	2011-12-20	2013-06-26	Sanofi	Neuartige therapeutische Verwendung von p75-Rezeptorantagonisten
CN121159506A (zh) *	2024-06-17	2025-12-19	青岛清原化合物有限公司	取代的芳基酰胺化合物或其盐及其制备方法、组合物和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3236243A1 (de) *	1982-09-30	1984-04-05	Merck Patent Gmbh, 6100 Darmstadt	Schwefelhaltige indolderivate
FR2744448B1 (fr) *	1996-02-02	1998-04-24	Pf Medicament	Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
WO1999001423A1 (en) *	1997-07-01	1999-01-14	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
US6613942B1 (en) *	1997-07-01	2003-09-02	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
EP1165522A1 (de)	1999-04-06	2002-01-02	Krenitsky Pharmaceuticals, Inc.	Neurotropische thio substituierte pyrimidinen
UA77526C2 (en) *	2002-06-07	2006-12-15	Sanofi Aventis	Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
FR2862968B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique
FR2862967B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
FR2932481B1 (fr) *	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.

2008
- 2008-06-13 FR FR0803299A patent/FR2932482B1/fr not_active Expired - Fee Related
2009
- 2009-06-04 JO JO2009204A patent/JO2774B1/en active
- 2009-06-11 AR ARP090102110A patent/AR072103A1/es active IP Right Grant
- 2009-06-11 TW TW098119564A patent/TWI432433B/zh active
- 2009-06-12 UY UY0001031893A patent/UY31893A/es not_active Application Discontinuation
- 2009-06-12 RS RS20120137A patent/RS52262B/sr unknown
- 2009-06-12 AT AT09761939T patent/ATE540039T1/de active
- 2009-06-12 EP EP09761939A patent/EP2297148B8/de active Active
- 2009-06-12 CN CN200980131366.XA patent/CN102124006B/zh active Active
- 2009-06-12 BR BRPI0915126A patent/BRPI0915126B8/pt active Search and Examination
- 2009-06-12 SI SI200930220T patent/SI2297148T1/sl unknown
- 2009-06-12 MX MX2010013695A patent/MX2010013695A/es active IP Right Grant
- 2009-06-12 CA CA2727669A patent/CA2727669C/fr active Active
- 2009-06-12 JP JP2011513038A patent/JP5476373B2/ja active Active
- 2009-06-12 KR KR1020117000792A patent/KR101642526B1/ko active Active
- 2009-06-12 PE PE2010001120A patent/PE20110154A1/es not_active Application Discontinuation
- 2009-06-12 DK DK09761939.9T patent/DK2297148T3/da active
- 2009-06-12 MY MYPI20105850 patent/MY150988A/en unknown
- 2009-06-12 PT PT09761939T patent/PT2297148E/pt unknown
- 2009-06-12 PL PL09761939T patent/PL2297148T3/pl unknown
- 2009-06-12 NZ NZ589840A patent/NZ589840A/xx not_active IP Right Cessation
- 2009-06-12 ES ES09761939T patent/ES2379685T3/es active Active
- 2009-06-12 WO PCT/FR2009/051118 patent/WO2009150388A1/fr not_active Ceased
- 2009-06-12 EA EA201170016A patent/EA019074B1/ru not_active IP Right Cessation
- 2009-06-12 HR HR20120290T patent/HRP20120290T1/hr unknown
- 2009-06-12 UA UAA201100370A patent/UA101979C2/ru unknown
- 2009-06-12 AU AU2009259121A patent/AU2009259121B2/en active Active
2010
- 2010-12-08 CR CR11832A patent/CR11832A/es unknown
- 2010-12-08 DO DO2010000380A patent/DOP2010000380A/es unknown
- 2010-12-09 IL IL209902A patent/IL209902A/en active IP Right Grant
- 2010-12-09 SV SV2010003755A patent/SV2010003755A/es unknown
- 2010-12-10 EC EC2010010672A patent/ECSP10010672A/es unknown
- 2010-12-10 NI NI201000215A patent/NI201000215A/es unknown
- 2010-12-13 CL CL2010001429A patent/CL2010001429A1/es unknown
- 2010-12-13 US US12/966,413 patent/US8193190B2/en active Active
- 2010-12-13 CO CO10156029A patent/CO6280535A2/es active IP Right Grant
2011
- 2011-01-13 MA MA33517A patent/MA32474B1/fr unknown
2012
- 2012-04-04 CY CY20121100339T patent/CY1112610T1/el unknown
- 2012-05-17 US US13/473,885 patent/US8519143B2/en active Active
2013
- 2013-06-04 DO DO2013000124A patent/DOP2013000124A/es unknown

Also Published As

Publication number	Publication date
US8519143B2 (en)	2013-08-27
BRPI0915126A2 (pt)	2016-02-16
ECSP10010672A (es)	2011-01-31
WO2009150388A1 (fr)	2009-12-17
SI2297148T1 (sl)	2012-05-31
CN102124006A (zh)	2011-07-13
CY1112610T1 (el)	2016-02-10
TW201002710A (en)	2010-01-16
UY31893A (es)	2010-01-29
EA201170016A1 (ru)	2011-08-30
AR072103A1 (es)	2010-08-04
MY150988A (en)	2014-03-31
US20120232280A1 (en)	2012-09-13
US8193190B2 (en)	2012-06-05
PT2297148E (pt)	2012-04-03
KR20110018435A (ko)	2011-02-23
AU2009259121B2 (en)	2013-12-19
US20110144116A1 (en)	2011-06-16
EP2297148A1 (de)	2011-03-23
EP2297148B8 (de)	2012-03-28
JP2011522869A (ja)	2011-08-04
CA2727669A1 (fr)	2009-12-17
AU2009259121A1 (en)	2009-12-17
IL209902A (en)	2014-09-30
IL209902A0 (en)	2011-02-28
PE20110154A1 (es)	2011-03-14
BRPI0915126B8 (pt)	2021-05-25
JP5476373B2 (ja)	2014-04-23
TWI432433B (zh)	2014-04-01
CO6280535A2 (es)	2011-05-20
NI201000215A (es)	2011-05-04
EP2297148B1 (de)	2012-01-04
HRP20120290T1 (hr)	2012-04-30
BRPI0915126B1 (pt)	2019-09-24
DOP2013000124A (es)	2013-12-31
JO2774B1 (en)	2014-03-15
NZ589840A (en)	2012-11-30
CN102124006B (zh)	2014-06-11
CR11832A (es)	2011-02-04
PL2297148T3 (pl)	2012-05-31
RS52262B (sr)	2012-10-31
CL2010001429A1 (es)	2011-07-29
HK1158631A1 (en)	2012-07-20
ES2379685T3 (es)	2012-04-30
MA32474B1 (fr)	2011-07-03
MX2010013695A (es)	2011-03-04
DK2297148T3 (da)	2012-05-07
KR101642526B1 (ko)	2016-07-25
EA019074B1 (ru)	2013-12-30
DOP2010000380A (es)	2011-01-15
CA2727669C (fr)	2016-08-23
UA101979C2 (ru)	2013-05-27
SV2010003755A (es)	2011-03-15
FR2932482B1 (fr)	2010-10-08
FR2932482A1 (fr)	2009-12-18

Publication	Publication Date	Title
DE602007013295D1 (de)	2011-04-28	Substituierte isochinoline und ihre verwendung als rho-kinase-inhibitoren
DK2193118T3 (da)	2012-10-22	Piperidin- og piperazinderivater til behandling af tumorer
ATE546433T1 (de)	2012-03-15	Quinolinderivate und ihre verwendung als fungizide
EP2140005A4 (de)	2010-04-21	Antagonisten von liganden und verwendungen davon
ATE472546T1 (de)	2010-07-15	5-heteroarylthiazole und deren verwendung als pi3k-inhibitoren
HRP20151052T1 (xx)	2015-11-06	Peteroäślani heterocikliäśki amidi i srodne tvari
ATE513822T1 (de)	2011-07-15	Benzothiazepinderivate und ihre verwendung als modulatoren von ampa und nmda rezeptoren
DE102008063992A8 (de)	2010-12-16	Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
DE602005022115D1 (de)	2010-08-12	Heteroaromatische chinolinverbindungen und deren verwendung als pde10-inhibitoren
ATE489389T1 (de)	2010-12-15	2 -heteroaryl- pyrrolo ä3, 4-cüpyrrol- derivate und deren verwendung als scd inhibitoren
ATE548355T1 (de)	2012-03-15	4- (4-cyano-2-thioaryl) -dihydropyrimidinone und ihre verwendung
EP2373163A4 (de)	2012-10-24	Heterocyclische verbindungen und anwendungsverfahren
EP2268813A4 (de)	2012-10-10	Rna-moleküle und ihre verwendung
CL2011000846A1 (es)	2011-09-30	Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
ATE486856T1 (de)	2010-11-15	Benzimidazol-derivate und ihre verwendung zur modulierung des gabaa-rezeptor-komplexes
DE112007000789A5 (de)	2009-01-02	Verwendung von Bora-tetraazepentalenen
ATE478059T1 (de)	2010-09-15	Cinnamoylpiperazinderivate und ihre verwendung als par-1-antagonisten
DE602007011897D1 (de)	2011-02-24	Neue aminoalkohol-substituierte aryldihydroisochinolinone, herstellungsverfahren und ihre verwendung als medikamente
EP2421548A4 (de)	2012-09-26	Verwendung von (hexenoyl-trans-3)hgrf(l-44)nh2 und simvastatin in einer kombinationstherapie
DE602007010179D1 (de)	2010-12-09	Piperidinylaminopyridazine und ihre verwendung als schnelldissoziierende antagonisten des dopamin-2-rezeptors
EP2388320A4 (de)	2012-11-07	Anti-hs6st2-antikörper und verwendung davon
EP2343087A4 (de)	2012-08-01	Neuartiger knorpelzellenproliferations- und differenzierungsinduzierer
MA32474B1 (fr)	2011-07-03	Nouveaux derives de (piperazinyl ponte) -1-alcanone et leur utilisation comme inhibiteurs de p75
DE602005006101D1 (de)	2008-05-29	Substituierte chinoline und deren verwendung als inhibitoren von mycobakterien
ATE517098T1 (de)	2011-08-15	Acylaminothiazolderivate und deren verwendung als beta-amyloid-inhibitoren